The Diary Of A CEO with Steven Bartlett

Podbit · The Diary Of A CEO with Steven Bartlett

Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!

Explore episode Jul 16, 2026
Health & Fitness
Ketosis + Chemo: Using Lower Doses for Bigger Results

Leading Cancer Researcher: They’re Ignoring My Research, Ca… · Jul 16, 2026 Health & Fitness

When cancer patients enter nutritional ketosis before chemotherapy, tumour cells lose their metabolic shield — the lactic acid and succinic acid waste that normally protects them. The result: far lower doses of chemo achieve much greater effect, while healthy cells are protected by their ability to slow down. Istanbul clinics are already doing this with pancreatic cancer patients surviving 4–5 years.

Where this was said

Using the Keto Diet to Supercharge Chemo

At 58:50 · chapter starts 58:35

The most clinically actionable section of the episode, this chapter lays out precisely how Seyfried's metabolic approach transforms standard treatment. Cancer cells are protected in part by the fermentation waste products — lactic acid and succinic acid — they dump into the tumour microenvironment; these metabolites actively block chemotherapy and immunotherapy from working. When a patient is put into nutritional ketosis, glucose supply to the tumour drops, fermentation slows, and this chemical shield is stripped away. Healthy cells, meanwhile, switch to burning ketones and enter a slower, more protective metabolic state — what Bartlett memorably summarises as 'bunker mode' — making them far more resistant to chemotherapy's toxicity. The result: the same anti-cancer effect with dramatically lower drug doses, fewer side effects, and a preserved microbiome and immune system. Seyfried describes Istanbul clinics achieving 4–5 year survival in patients with terminal pancreatic cancer using this exact combination. He also explains how immunotherapy works better when applied after metabolic therapy has made the tumour indolent and isolated — attacking a weakened foe rather than a raging one. Mainstream oncology's sequencing, he argues, gets this backwards.

Health & Fitness
The Press-Pulse Strategy: A Logical Plan to Manage Cancer

Leading Cancer Researcher: They’re Ignoring My Research, Ca… · Jul 16, 2026 Health & Fitness

The press-pulse therapeutic strategy first 'presses' — restricts glucose via ketogenic diet and fasting to starve the tumour and reduce its aggressiveness. Then it 'pulses' — delivers drugs targeting glutamine to kill the now-weakened cancer cells, particularly the metastatic hybrids. Low-dose chemo and immunotherapy then finish off what remains, attacking the tumour at its weakest.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.